Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies

Journal of Neuroimmunology

Volumn 104, Issue 2, 2000, Pages 155-163

  Ritz, Marie Françoise ^a   Lechner Scott, Jeannette ^a   Scott, Rodney J ^a   Fuhr, Peter ^a   Malik, Nass ^b   Erne, Beat ^a   Taylor, Verdon ^c   Suter, Ueli ^c   Schaeren Wiemers, Nicole ^a   Steck, Andreas J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Humangenetik   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Acquired neuropathy; Autoantibody; Charcot Marie Tooth disease; Hereditary neuropathy; Peripheral myelin protein 22

Indexed keywords

AUTOANTIBODY; MYELIN PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; ELECTROPHYSIOLOGY; HUMAN; MYELIN SHEATH; NEUROPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADULT; AGED; AUTOANTIBODIES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHARCOT-MARIE-TOOTH DISEASE; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; MYELIN PROTEINS; POLYNEUROPATHIES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RECOMBINANT PROTEINS;

EID: 18144436151     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00250-7     Document Type: Article

References (42)

1. Abo T., Bach C.M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127:1981;1024-1029.
2. Antoine J.C., Michel D., Kopp N., Gonnaud P.M., Laurent B. Neuropathies périphériques chroniques díallure hérédodégénérative corticosensibles: deux cas. Rev. Neurol. 145:1989;469-473.
3. Bergoffen J., Scherer S.S., Wang S., Scott M.O., Bonbe I.J., Paul D.L., Chen K., Lensch M.W., Chance P.F., Fischbeck K.H. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2042.
4. Birouk N., Gouider R., Le Guern E., Gugenheim M., Tardieu S., Maisonobe T., Le Forestier N., Agid Y., Brice A., Bouche P. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain. 120:1997;813-823.
5. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophtalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome. Neurology. 43:1993;1911-1917.
6. De Visser M. Diagnostic criteria for autosomal dominant hereditary motor and sensory neuropathy type 1a. Neuromusc. Disord. 3:1993;77-79.
7. Dyck P.J., Swanson C.J., Low P.A., Bartelson J.D., Lambert E.H. Prednison-responsive hereditary motor and sensory neuropathy. Mayo Clin. Proc. 57:1982;239-246.
8. Gabreels-Festen A.A., Gabreels F.J. Hereditary demyelinating motor and sensory neuropathy. Brain Pathol. 3:1993;135-146.
9. Gabriel J.M., Erne B., Pareyson D., Sghirlanzoni A., Taroni F., Steck A.J. Gene dosage effects in hereditary peripheral neuropathy. Neurology. 49:1997;1635-1640.
10. Gabriel C.M., Hughes R.A.C., Moore S.E., Smith K.J., Walsh F.S. Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain. 121:1998;1895-1902.
11. Graham F.L., Van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456.
12. Haites N.E., Nelis E., Van Broekhoven C. Third workshop of the European CMT Consortium: 54th ENMC International Workshop on genotype/phenotype correlations in Charcot-Marie-Tooth type 1 and hereditary neuropathy with liability to pressure palsies. Neuromusc. Disord. 8:1998;591-601.
13. Hammer J.A., O'Shannessy D.J., De Leon M., Gould R., Zand D., Daune G., Quarles R.H. Immunoreactivity of PMP22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J. Neurosci. Res. 35:1993;546-558.
14. Hayasaka K., Himoro M., Sato W., Takada G., Uyemura K., Shimizu N., Bird T.D., Conneally P.M., Chance P.F. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the P0 gene. Nat. Genet. 5:1993;31-34.
15. Huxley C., Passage E., Robertson A.M., Youl B., Huston S., Manson A., Saberan-Djoniedi D., Figarella-Branger D., Pellisier J.F., Thomas P.K., Fontes M. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. Mol. Genet. 7:1998;449-458.
16. Koehler N.K., Martin R., Wiethotter H. The antibody repertoire in experimental allergic neuritis: evidence for PMP22 as a novel neuritogen. J. Neuroimmunol. 71:1996;179-189.
17. Latov N., Hays A.P., Sherman W.H. Peripheral neuropathy and anti-MAG antibodies. CRC Crit. Rev. Neurobiol. 3:1988;301-332.
18. Lechner-Scott J.S., Scott R.J., Steck A.J., Kappos L. Hereditäre motorisch-sensible neuropathien. Schweiz. Arch. Neurol. Psych. 146:1995;157-167.
19. Lupski J.R., Montes de Oca-Luna R., Slaugenhaupt S.I., Pentoa L., Guzzerra V., Trask B.J., Saucedo-Cardenas O., Barker D.F., Killian J.M., Garcia C.A., Chakravarti A., Patel P. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 66:1991;219-232.
20. Lupski J.R., Wise C.A., Kuwano A., Pentao L., Parke J.T., Glaze D.G., Ledbetter D.H., Greenberg F., Patel P.I. Gene dosage effect is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1:1992;29-33.
21. Magyar J.P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K.V., Suter U. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16:1996;5351-5360.
22. Manfioletti G., Ruaro M.E., Del Sal G., Philipson L., Schneider C. A growth-arrest specific (gas) gene codes for a membrane protein. Mol. Cell. Biol. 10:1990;2924-2930.
23. Matsunami N., Smith B., Ballard L., Lensch M.W., Robertson M., Albertson H., Hanemann C.O., Müller H.W., Bird T.D., White R., Chance P.F. Peripheral myelin protein 22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat. Genet. 1:1992;176-179.
24. Naef R., Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Micros. Res. Tech. 41:1998;359-371.
25. Navon R., Seifried B., Gal-On N.S., Sadeh M. A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe de novo Charcot-Marie-Tooth disease. Hum. Genet. 97:1996;685-687.
26. Nelis E., Timmerman V., De Jonghe P., Pareek S., Suter U., Snipes G.J., Welcher A.A., Shooter E.M., Murphy R.A. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J. Biol. Chem. 268:1993;10372-10379.
27. Nelis E., De Jonghe P., De Vriendt E., Patel P.I., Martin J.J., Van Broeckhoven C. Mutation analysis of the nerve specific promoter of the peripheral myelin protein 22 gene in CMT1A disease and HNPP. J. Med. Genet. 35:1998;590-593.
28. Patel P.I., Roa B.B., Welcher A.A., Schoener-Scott R., Trash B.J., Pentao L., Snipes G.J., Garcia C.A., Francke U., Shooter E.M., Lupski J.R., Suter U. The gene for the peripheral myelin protein PMP22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1:1992;159-165.
29. Raeymaekers P., Timmerman V., Nelis E., De Jinghe P., Hoogendijk J.E., Baas F., Barker D.F. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul. Disord. 1:1991;93-97.
30. Roa B.B., Garcia C.A., Suter U., Kulpa D.A., Wise C.A., Mueller J., Welcher A.A., Snipes G.J., Shooter E.M., Patel P.I., Lupski J.R. Charcot-Marie-Tooth type 1A: association with a spontaneous point mutation in the PMP22 gene. N. Engl. J. Med. 329:1993;96-101.
31. Roa B.B., Greenberg F., Gunaratne P., Sauer C.M., Lubinksy M.S., Kozma C., Meck J.M., Magenis R.E., Shaffer L.G., Lupski J.R. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type 1A neuropathy. Hum. Genet. 97:1996;642-649.
32. Sereda M., Griffiths I., Pulhofer A., Stewart H., Rossner M.J., Zimmermann F., Magyar J.P., Schneider A., Hund E., Meink H.M., Suter U., Nave K.A. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
33. Schneider C., King R.M., Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 54:1988;787-793.
34. Snipes G.J., Suter U. Molecular anatomy and genetics of myelin proteins in peripheral nervous system. J. Anat. 186:1995;483-494.
35. Snipes G.J., Suter U., Shooter E.M. Human peripheral myelin protein 22 carries the L2/HNK1 carbohydrate adhesion epitope. J. Neurochem. 61:1993;1961-1964.
36. Timmermann V., Nelis E., Van Hul W., Nieuwenhuijsen B.W., Chen K.L., Ben Othman K., Cullen B., Leachz R.J., Hanemann C.O., De Jonghe P., Raeymaekers P., van Ommen G.-J.B., Martin J.J., Müller H.W., Vance J.M., Fishbeck K.H., Van Broeckhoven C. The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat. Genet. 1:1992;171-175.
37. Valentijn L.J., Baas F., Wolterman R.A., Hoogendijk J.E., van den Bosch N.H.A., Zorn I., Grabreels-Festen A.A., de Visser M., Bolhuis P.A. Identical point mutation of PMP22 in TremblerJ mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2:1993;288-291.
38. Vallat J.M., Sindou P., Preux P.M., Tabaraud F., Milor A.M., Couratier P., LeGuern E., Brice A. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann. Neurol. 39:1996;813-817.
39. Willison H.J., Veitch J., Patterson G., Kennedy P.G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry. 56:1993;204-206.
40. Yoshikawa H., Nishimura T., Nakatsuji Y., Fujimura H., Himoro M., Hayasaka K., Sakjoda S., Yanagihara T. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann. Neurol. 35:1994;445-450.
41. Yoshioka R., Dyck P.J., Chance P.F. Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type2. Neurology. 46:1996;569-571.
42. Zoidl G., D'Urso D., Blass-Kampmann S., Schmalenbach C., Kuhn R., Müller H.W. Influence of elevated expression of rat wild type PMP22 and its mutant PMP22 (Trembler) on cell growth of NIH3T3 fibroblasts. Cell Tissue Res. 287:1997;459-470.